Beraprost therapy for pulmonary arterial hypertension
Top Cited Papers
- 1 June 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (12), 2119-2125
- https://doi.org/10.1016/s0735-1097(03)00463-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin AnalogueNew England Journal of Medicine, 2000
- Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled TrialAnnals of Internal Medicine, 2000
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Beraprost SodiumCardiovascular Drug Reviews, 1988
- Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue.The Japanese Journal of Pharmacology, 1987
- Vasodilator actions of TRK‐100, a new prostaglandin I2 analogueBritish Journal of Pharmacology, 1986